Seoul
South Korea
10
2021-04-22
6
2023-07-04
These are the the leading inventors for applications assigned to pH PHARMA CO., LTD.:
pH PHARMA CO., LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES FOR TREATING CHRONIC WOUNDS
#2 | 2021-03-11USE OF NEUTROPHIL ELASTASE INHIBITORS IN LIVER DISEASE
#3 | 2020-12-31 ✅ Patent 11,691,982 granted on 2023-07-04Thailanstatin analogs
#4 | 2020-07-09THAILANSTATIN ANALOGS
#5 | 2019-10-24 ✅ Patent 10,806,735 granted on 2020-10-20Use of neutrophil elastase inhibitors in liver disease
#6 | 2019-08-15 ✅ Patent 10,676,443 granted on 2020-06-09Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile
#7 | 2019-08-01 ✅ Patent 10,815,246 granted on 2020-10-27Thailanstatin analogs
#8 | 2019-03-21 ✅ Patent 10,301,319 granted on 2019-05-28Thailanstatin analogs
#9 | 2019-01-104-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES FOR TREATING CHRONIC WOUNDS
#10 | 2018-03-15 ✅ Patent 10,316,001 granted on 2019-06-11Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile
Also check out pH Pharma Co., Ltd.'s (Seoul, South Korea) applicant profile with 6 patent applications submitted.
143813 ⎘